investor losses

Rosen Law Firm investigates Phoenix Education Partners for allegedly misleading investors about a data breach affecting 3.5 million people. Shareholders encouraged to seek legal counsel.

PennyMac Financial faces securities investigation for allegedly misleading investors about servicing segment performance. Stock plummeted 33% after fourth quarter earnings decline.

uniQure faces securities class action over allegedly misleading FDA approval claims and timeline delays. Investors must act before April 13, 2026 deadline.

Rosen Law Firm investigates Lufax for potential securities violations after the fintech company removed auditors and delayed its annual report, causing stock to plunge 13.8%.

Law firm investigates Cogent Communications for potential securities violations following 6% revenue decline and 98% dividend cut that tanked stock 35%.

Hub Group restated 2025 financials after discovering material accounting errors in transportation costs and payables. Stock fell 18.3%, triggering shareholder lawsuits over disclosure adequacy.

Law firm files class actions against Bath & Body Works and BellRing Brands for allegedly failing to disclose material information about business challenges, resulting in significant investor losses.

CoreWeave investors have until March 13, 2026 to join securities lawsuit alleging material misstatements about operational capacity and supplier risks.

REGENXBIO faces securities fraud lawsuit over alleged misrepresentations about RGX-111's safety and efficacy. A CNS tumor discovery contradicted prior investor statements, causing shareholder losses.

Schall Law Firm filed a securities class action against Kyndryl for allegedly making false financial disclosures and failing to maintain proper internal controls between August 2024 and February 2026.

Securities fraud lawsuit filed against uniQure for allegedly making false statements about FDA approval processes and BLA submission timelines, causing investor losses.

Law firm investigates GRAIL for potential securities violations after cancer trial failure triggered stock decline. Examining whether company adequately disclosed trial risks.

PayPal faces class action lawsuit alleging false statements about Branded Checkout growth prospects. Investors who purchased securities Feb 2025-Feb 2026 invited to join litigation.

Class action lawsuit filed against China Liberal Education for alleged pump-and-dump scheme using fake investment advisors on social media to inflate stock price before January collapse.

NuScale Power faces class action lawsuit alleging misrepresentations about partner ENTRA1's nuclear experience. Shareholders claim undisclosed experience deficiencies pose risks to company's commercialization strategy.

Class action lawsuit alleges uniQure withheld FDA study design concerns from investors, causing 49% stock decline after disclosure in November 2025.

Law firm sues China Liberal Education Holdings for securities fraud, alleging misleading statements about share manipulation in January 2025. Seeking lead plaintiffs from affected investors.

Class action lawsuit filed against Varonis Systems for allegedly making false statements about SaaS conversion abilities. Stock plunged 48.67% after missing revenue guidance.

Class action lawsuit filed against Bath & Body Works for allegedly making false growth claims. Investors who suffered losses between June 2024 and November 2025 may seek damages.

Class action filed against Fermi Inc. over false IPO disclosures regarding tenant demand and funding stability for Project Matador campus development.